[1]张顺财, 孙剑勇.脂肪肝的动物模型[J].肝脏, 2001, 6 (3) ∶192~194.
|
[2]钟岚, 范建高, 王国良, 等.肥胖、高脂血症性脂肪肝肝炎模型的建立[J].实验动物科学与管理, 2000, 17 (2) ∶16~20.
|
[3]阎向东, 郑珊, 熊晓燕.四氯化碳与乙醇经口所致小鼠肝损伤病理模型重现性的比较[J].毒理学杂志, 2005, 19 (2) ∶136~138.
|
[4]Hautekeete ML.Hepatotoxicity of antibiotics[J].Acta Gastro-en-terologica Belgica, 1995, 58 (3-4) ∶290~296.
|
[5]Amacher DE, Martin BA.Tetracycline-induced steatosis in primarycanine hepatocyte cultures[J].Fundamental and Applied toxicology, 1997, 40 (2) ∶256~263.
|
[6]Letteron P, Sutton A, Mansouri A, et al.Inhibition of microsomaltriglyceride transfer protein:another mechanism for drug-inducedsteatosis in mice[J].Hepatology, 2003, 38 (1) ∶133~140.
|
[1] | Jiamin MA, Lulu GAO, Mengwei ZHANG, Qinghan GAO, Xiujuan TAO, Yanna FAN, Jianjun YANG. Role and mechanism of Lycium barbarum polysaccharide combined with aerobic exercise in improving nonalcoholic steatohepatitis in rats[J]. Journal of Clinical Hepatology, 2021, 37(6): 1348-1353. doi: 10.3969/j.issn.1001-5256.2021.06.026 |
[2] | Ding Jie, Wang Liang, Li Juan, Kong Yin, Zhao Rui, He JingJing, Li GuangMing, Wang JuanXia, Zhang LingYi. Changes in serum asymmetric dimethylarginine levels in progression of liver inflammation in an experimental rat model of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2016, 32(1): 148-151. doi: 10.3969/j.issn.1001-5256.2016.01.029 |
[3] | Huang YaoBin, Li HuanMin, Li ChunGuang. Association of cholecystectomy with non-alcoholic fatty liver[J]. Journal of Clinical Hepatology, 2014, 30(7): 644-646. doi: 10.3969/j.issn.1001-5256.2014.07.017 |
[4] | Zhu JinZhao, Rao JunWei, Lu: Yong, Li Huan. Changes in distribution of cholinergic and nitrergic nerves in antrum of rats with liver failure[J]. Journal of Clinical Hepatology, 2014, 30(10): 1023-1026. doi: 10.3969/j.issn.1001-5256.2014.10.012 |
[5] | Wang WeiZhen, Meng MingHui, Kong Li, Zhang QingShan, Zhao SuXian, Nan YueMin. Role of Jak /Stat pathway in CCl4- induced rat liver fibrosis model and molecular action mechanism of Fuzheng Huayu recipe in treatment of liver fibrosis[J]. Journal of Clinical Hepatology, 2014, 30(4): 344-348. doi: 10.3969/j.issn.1001-5256.2014.04.014 |
[6] | Xu LaMei, Sun DanLi, Zhang YuShu, Zhang ZhenYu, Yuan Jie, Du TongXin. The clinical significance of adiponectin expression and its diagnostic value combined with liver function tests and liver/spleen CT value in Non-alcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2010, 26(2): 170-172. |
[7] | Nong XiTing, Huang Hua, Qin Rong, Lu MingLiang. The Changes in substance P in jejunum of fatty liver[J]. Journal of Clinical Hepatology, 2010, 26(1): 33-35. |
[8] | Ma LiNa, Feng Ming, Zhou YingZhi, Ma Jia, Hao Peng. The relationship between nonalcoholic fatty liver disease and insulin resistance[J]. Journal of Clinical Hepatology, 2010, 26(2): 173-174+177. |
[9] | Zhang JinHua, Long Hui, Liu Qun, Wang GuiFang. Analysis of risk factors of type 2 diabetes in patients with Nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2009, 25(2): 129-130. |
[10] | Song MinNing, Chen Fu, Song YuNa, Xie ZeJin. The influence of 5-hydroxytryptamine on rat with hepatic encephalopathy.[J]. Journal of Clinical Hepatology, 2008, 24(2): 88-91. |
[11] | Qin Gang, Shi GuangFeng, Li Qian, Lu Qing, Chen Shu. Inhibitory effects of UDCA on porcine serum-induced rat liver fibrosis[J]. Journal of Clinical Hepatology, 2007, 23(4): 263-265. |
[12] | Yu XiaoHu, Zhu JinShui, Gu GuoMei, Shi JianPing. Clinical effect of oxymatrine combined with metformin on insulin resistance and serum TNF-α in patients with non-alcoholic fatty liver[J]. Journal of Clinical Hepatology, 2007, 23(3): 195-196. |
[14] | Liu FengHai, Sun LinYu, Tan HaiYan, Liu XiaoLi. The clinical significance of serum leptin levels in patients with nonalcoholic fatty liver[J]. Journal of Clinical Hepatology, 2006, 22(1): 41-42. |
[16] | Lu ZhenYa, Wang QunYan, Rao WeiQiang, Cai WeiMin. Relationship between leptin resistance and nonalcoholic fatty liver in male patients.[J]. Journal of Clinical Hepatology, 2006, 22(1): 39-41. |
[17] | Liang Bing, Chen Xi, Liu ShuangYan, Wang YiGe, An QiuHong. The relationship between non-alcoholic fatty liver disease and insulin resistance[J]. Journal of Clinical Hepatology, 2006, 22(3): 213-214. |
[18] | Chu YanJun, Lu YanRu. Effects of spirulina in prevention of liver fibrosis in rats[J]. Journal of Clinical Hepatology, 2003, 19(6): 372-373. |
[19] | Ma YingJie, Fang LiFeng, Feng SuPing, Jia KeLi, Fu ZhenLie. Obesity and insulin resistance in nonalcoholic fatty liver[J]. Journal of Clinical Hepatology, 2002, 18(4): 241-242. |